[English] 日本語
Yorodumi
- PDB-2mzz: NMR structure of APOBEC3G NTD variant, sNTD -

+
Open data


ID or keywords:

Loading...

-
Basic information

Entry
Database: PDB / ID: 2mzz
TitleNMR structure of APOBEC3G NTD variant, sNTD
ComponentsApolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G variant
KeywordsHydrolase / Antiviral protein / Vif-binding domain
Biological speciesartificial gene (others)
MethodSOLUTION NMR / simulated annealing
Model detailsminimized average structure, model1
Model type detailsminimized average
AuthorsKouno, T. / Luengas, E.M. / Shigematu, M. / Shandilya, S.M.D. / Zhang, J. / Chen, L. / Hara, M. / Schiffer, C.A. / Harris, R.S. / Matsuo, H.
CitationJournal: Nat.Struct.Mol.Biol. / Year: 2015
Title: Structure of the Vif-binding domain of the antiviral enzyme APOBEC3G.
Authors: Kouno, T. / Luengas, E.M. / Shigematsu, M. / Shandilya, S.M. / Zhang, J. / Chen, L. / Hara, M. / Schiffer, C.A. / Harris, R.S. / Matsuo, H.
History
DepositionFeb 28, 2015Deposition site: BMRB / Processing site: RCSB
Revision 1.0May 13, 2015Provider: repository / Type: Initial release
Revision 1.1Jun 3, 2015Group: Database references
Revision 1.2Jul 1, 2015Group: Database references
Revision 1.3Jun 14, 2023Group: Data collection / Database references ...Data collection / Database references / Derived calculations / Other
Category: database_2 / pdbx_database_status ...database_2 / pdbx_database_status / pdbx_nmr_software / pdbx_nmr_spectrometer / pdbx_struct_conn_angle / struct_conn / struct_site
Item: _database_2.pdbx_DOI / _database_2.pdbx_database_accession ..._database_2.pdbx_DOI / _database_2.pdbx_database_accession / _pdbx_database_status.status_code_nmr_data / _pdbx_nmr_software.name / _pdbx_nmr_spectrometer.model / _pdbx_struct_conn_angle.ptnr1_auth_seq_id / _pdbx_struct_conn_angle.ptnr1_label_seq_id / _pdbx_struct_conn_angle.ptnr3_auth_seq_id / _pdbx_struct_conn_angle.ptnr3_label_seq_id / _pdbx_struct_conn_angle.value / _struct_conn.pdbx_dist_value / _struct_conn.ptnr1_auth_seq_id / _struct_conn.ptnr1_label_seq_id / _struct_site.pdbx_auth_asym_id / _struct_site.pdbx_auth_comp_id / _struct_site.pdbx_auth_seq_id
Revision 1.4May 15, 2024Group: Data collection / Database references / Category: chem_comp_atom / chem_comp_bond / database_2 / Item: _database_2.pdbx_DOI

-
Structure visualization

Structure viewerMolecule:
MolmilJmol/JSmol

Downloads & links

-
Assembly

Deposited unit
A: Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G variant
hetero molecules


Theoretical massNumber of molelcules
Total (without water)21,3812
Polymers21,3161
Non-polymers651
Water00
1


  • Idetical with deposited unit
  • defined by author
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
NMR ensembles
DataCriteria
Number of conformers (submitted / calculated)10 / 100structures with the lowest energy
RepresentativeModel #1minimized average structure

-
Components

#1: Protein Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G variant


Mass: 21316.049 Da / Num. of mol.: 1
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) artificial gene (others) / Production host: Escherichia coli (E. coli)
#2: Chemical ChemComp-ZN / ZINC ION


Mass: 65.409 Da / Num. of mol.: 1 / Source method: obtained synthetically / Formula: Zn

-
Experimental details

-
Experiment

ExperimentMethod: SOLUTION NMR
NMR experiment
Conditions-IDExperiment-IDSolution-IDType
1112D 1H-15N TROSY
1223D HNCA-TROSY
1323D HN(CO)CA-TROSY
1423D HNCO-TROSY
1523D HN(CA)CO-TROSY
1623D HN(CA)CB-TROSY
1723D HN(CO)CACB-TROSY
1833D 15N-edited NOESY
1942D 1H-15N TROSY
11052D 1H-15N TROSY
11162D 1H-15N TROSY
11272D 1H-15N TROSY
11382D 1H-15N TROSY
11492D 1H-15N TROSY
115102D 1H-13C HSQC
116112D 1H-13C HSQC
117122D 1H-13C HSQC
118132D 1H-13C HSQC
119142D 1H-13C HSQC
120152D 1H-13C HSQC
121162D 1H-13C HSQC
122172D 1H-13C HSQC
123182D 1H-13C HSQC
124192D 1H-13C HSQC
125102D 1H-1H NOESY
126112D 1H-1H NOESY
127122D 1H-1H NOESY
128132D 1H-1H NOESY
129142D 1H-1H NOESY
130152D 1H-1H NOESY
131162D 1H-1H NOESY
132172D 1H-1H NOESY
133182D 1H-1H NOESY
134192D 1H-1H NOESY
135202D 1H-1H NOESY
136212D 1H-1H NOESY
137222D 1H-1H NOESY
138232D 1H-1H NOESY
139242D 1H-1H NOESY
14033D 1H-13C NOESY

-
Sample preparation

Details
Solution-IDContentsSolvent system
10.15-0.20 mM [U-100% 15N; U-85% 2H] sNTD, 10 mM sodium phosphate, 100 mM sodium chloride, 0.005 % Tween 20, 0.5 mM TCEP, 0.01 % sodium azide, 0.5 M [U-98% 2H] Choline o-sulfate, 95% H2O/5% D2O95% H2O/5% D2O
20.15-0.20 mM [U-100% 13C; U-100% 15N; U-85% 2H] sNTD, 10 mM sodium phosphate, 100 mM sodium chloride, 0.005 % Tween 20, 0.5 mM TCEP, 0.01 % sodium azide, 0.5 M [U-98% 2H] Choline o-sulfate, 95% H2O/5% D2O95% H2O/5% D2O
30.05-0.10 mM [U-100% 13C; U-100% 15N; U-60% 2H] sNTD, 10 mM sodium phosphate, 100 mM sodium chloride, 0.005 % Tween 20, 0.5 mM TCEP, 0.01 % sodium azide, 0.5 M [U-98% 2H] Choline o-sulfate, 95% H2O/5% D2O95% H2O/5% D2O
40.05-0.10 mM [U-80% 2H; 100% 15N-Arg] sNTD, 10 mM sodium phosphate, 100 mM sodium chloride, 0.005 % Tween 20, 0.5 mM TCEP, 0.01 % sodium azide, 0.5 M [U-98% 2H] Choline o-sulfate, 95% H2O/5% D2O95% H2O/5% D2O
50.05-0.10 mM [U-80% 2H; 100% 15N-Ile] sNTD, 10 mM sodium phosphate, 100 mM sodium chloride, 0.005 % Tween 20, 0.5 mM TCEP, 0.01 % sodium azide, 0.5 M [U-98% 2H] Choline o-sulfate, 95% H2O/5% D2O95% H2O/5% D2O
60.05-0.10 mM [U-80% 2H; 100% 15N-Leu] sNTD, 10 mM sodium phosphate, 100 mM sodium chloride, 0.005 % Tween 20, 0.5 mM TCEP, 0.01 % sodium azide, 0.5 M [U-98% 2H] Choline o-sulfate, 95% H2O/5% D2O95% H2O/5% D2O
70.05-0.10 mM [U-80% 2H; 100% 15N-Lys] sNTD, 10 mM sodium phosphate, 100 mM sodium chloride, 0.005 % Tween 20, 0.5 mM TCEP, 0.01 % sodium azide, 0.5 M [U-98% 2H] Choline o-sulfate, 95% H2O/5% D2O95% H2O/5% D2O
80.05-0.10 mM [U-80% 2H; 100% 15N-Phe] sNTD, 10 mM sodium phosphate, 100 mM sodium chloride, 0.005 % Tween 20, 0.5 mM TCEP, 0.01 % sodium azide, 0.5 M [U-98% 2H] Choline o-sulfate, 95% H2O/5% D2O95% H2O/5% D2O
90.05-0.10 mM [U-80% 2H; 100% 15N-Tyr] sNTD, 10 mM sodium phosphate, 100 mM sodium chloride, 0.005 % Tween 20, 0.5 mM TCEP, 0.01 % sodium azide, 0.5 M [U-98% 2H] Choline o-sulfate, 95% H2O/5% D2O95% H2O/5% D2O
100.05-0.10 mM [U-80% 2H; 100% 1H, 100% 13C-Ala] sNTD, 10 mM sodium phosphate, 100 mM sodium chloride, 0.005 % Tween 20, 0.5 mM TCEP, 0.01 % sodium azide, 0.5 M [U-98% 2H] Choline o-sulfate, 100% D2O100% D2O
110.05-0.10 mM [U-80% 2H; 100% 1H, 100% 13C-Arg] sNTD, 10 mM sodium phosphate, 100 mM sodium chloride, 0.005 % Tween 20, 0.5 mM TCEP, 0.01 % sodium azide, 0.5 M [U-98% 2H] Choline o-sulfate, 100% D2O100% D2O
120.05-0.10 mM [U-80% 2H; 100% 1H, 100% 13C-Ile] sNTD, 10 mM sodium phosphate, 100 mM sodium chloride, 0.005 % Tween 20, 0.5 mM TCEP, 0.01 % sodium azide, 0.5 M [U-98% 2H] Choline o-sulfate, 100% D2O100% D2O
130.05-0.10 mM [U-80% 2H; 100% 1H, 100% 13C-Leu] sNTD, 10 mM sodium phosphate, 100 mM sodium chloride, 0.005 % Tween 20, 0.5 mM TCEP, 0.01 % sodium azide, 0.5 M [U-98% 2H] Choline o-sulfate, 100% D2O100% D2O
140.05-0.10 mM [U-80% 2H; 100% 1H, 100% 13C-Lys] sNTD, 10 mM sodium phosphate, 100 mM sodium chloride, 0.005 % Tween 20, 0.5 mM TCEP, 0.01 % sodium azide, 0.5 M [U-98% 2H] Choline o-sulfate, 100% D2O100% D2O
150.05-0.10 mM [U-80% 2H; 100% 1H, 100% 13C-Met] sNTD, 10 mM sodium phosphate, 100 mM sodium chloride, 0.005 % Tween 20, 0.5 mM TCEP, 0.01 % sodium azide, 0.5 M [U-98% 2H] Choline o-sulfate, 100% D2O100% D2O
160.05-0.10 mM [U-80% 2H; 100% 1H, 100% 13C-Phe] sNTD, 10 mM sodium phosphate, 100 mM sodium chloride, 0.005 % Tween 20, 0.5 mM TCEP, 0.01 % sodium azide, 0.5 M [U-98% 2H] Choline o-sulfate, 100% D2O100% D2O
170.05-0.10 mM [U-80% 2H; 100% 1H, 100% 13C-Thr] sNTD, 10 mM sodium phosphate, 100 mM sodium chloride, 0.005 % Tween 20, 0.5 mM TCEP, 0.01 % sodium azide, 0.5 M [U-98% 2H] Choline o-sulfate, 100% D2O100% D2O
180.05-0.10 mM [U-80% 2H; 100% 1H, 100% 13C-Tyr] sNTD, 10 mM sodium phosphate, 100 mM sodium chloride, 0.005 % Tween 20, 0.5 mM TCEP, 0.01 % sodium azide, 0.5 M [U-98% 2H] Choline o-sulfate, 100% D2O100% D2O
190.05-0.10 mM [U-80% 2H; 100% 1H, 100% 13C-Val] sNTD, 10 mM sodium phosphate, 100 mM sodium chloride, 0.005 % Tween 20, 0.5 mM TCEP, 0.01 % sodium azide, 0.5 M [U-98% 2H] Choline o-sulfate, 100% D2O100% D2O
200.05-0.10 mM [U-80% 2H; 100% 1H-Phe,Tyr,Ile] sNTD, 10 mM sodium phosphate, 100 mM sodium chloride, 0.005 % Tween 20, 0.5 mM TCEP, 0.01 % sodium azide, 0.5 M [U-98% 2H] Choline o-sulfate, 100% D2O100% D2O
210.05-0.10 mM [U-80% 2H; 100% 1H-Phe,Tyr,Leu] sNTD, 10 mM sodium phosphate, 100 mM sodium chloride, 0.005 % Tween 20, 0.5 mM TCEP, 0.01 % sodium azide, 0.5 M [U-98% 2H] Choline o-sulfate, 100% D2O100% D2O
220.05-0.10 mM [U-80% 2H; 100% 1H-Phe,Tyr,Val] sNTD, 10 mM sodium phosphate, 100 mM sodium chloride, 0.005 % Tween 20, 0.5 mM TCEP, 0.01 % sodium azide, 0.5 M [U-98% 2H] Choline o-sulfate, 100% D2O100% D2O
230.05-0.10 mM [U-80% 2H; 100% 1H-Trp,Ile,Leu,Val] sNTD, 10 mM sodium phosphate, 100 mM sodium chloride, 0.005 % Tween 20, 0.5 mM TCEP, 0.01 % sodium azide, 0.5 M [U-98% 2H] Choline o-sulfate, 100% D2O100% D2O
240.15-0.20 mM sNTD, 10 mM sodium phosphate, 100 mM sodium chloride, 0.005 % Tween 20, 0.5 mM TCEP, 0.01 % sodium azide, 0.5 M [U-98% 2H] Choline o-sulfate, 100% D2O100% D2O
Sample
Conc. (mg/ml)UnitsComponentIsotopic labelingConc. range (mg/ml)Solution-ID
mMsNTD-1[U-100% 15N; U-85% 2H]0.15-0.201
10 mMsodium phosphate-21
100 mMsodium chloride-31
0.005 %Tween 20-41
0.5 mMTCEP-51
0.01 %sodium azide-61
0.5 MCholine o-sulfate-7[U-98% 2H]1
mMsNTD-8[U-100% 13C; U-100% 15N; U-85% 2H]0.15-0.202
10 mMsodium phosphate-92
100 mMsodium chloride-102
0.005 %Tween 20-112
0.5 mMTCEP-122
0.01 %sodium azide-132
0.5 MCholine o-sulfate-14[U-98% 2H]2
mMsNTD-15[U-100% 13C; U-100% 15N; U-60% 2H]0.05-0.103
10 mMsodium phosphate-163
100 mMsodium chloride-173
0.005 %Tween 20-183
0.5 mMTCEP-193
0.01 %sodium azide-203
0.5 MCholine o-sulfate-21[U-98% 2H]3
mMsNTD-22[U-80% 2H; 100% 15N-Arg]0.05-0.104
10 mMsodium phosphate-234
100 mMsodium chloride-244
0.005 %Tween 20-254
0.5 mMTCEP-264
0.01 %sodium azide-274
0.5 MCholine o-sulfate-28[U-98% 2H]4
mMsNTD-29[U-80% 2H; 100% 15N-Ile]0.05-0.105
10 mMsodium phosphate-305
100 mMsodium chloride-315
0.005 %Tween 20-325
0.5 mMTCEP-335
0.01 %sodium azide-345
0.5 MCholine o-sulfate-35[U-98% 2H]5
mMsNTD-36[U-80% 2H; 100% 15N-Leu]0.05-0.106
10 mMsodium phosphate-376
100 mMsodium chloride-386
0.005 %Tween 20-396
0.5 mMTCEP-406
0.01 %sodium azide-416
0.5 MCholine o-sulfate-42[U-98% 2H]6
mMsNTD-43[U-80% 2H; 100% 15N-Lys]0.05-0.107
10 mMsodium phosphate-447
100 mMsodium chloride-457
0.005 %Tween 20-467
0.5 mMTCEP-477
0.01 %sodium azide-487
0.5 MCholine o-sulfate-49[U-98% 2H]7
mMsNTD-50[U-80% 2H; 100% 15N-Phe]0.05-0.108
10 mMsodium phosphate-518
100 mMsodium chloride-528
0.005 %Tween 20-538
0.5 mMTCEP-548
0.01 %sodium azide-558
0.5 MCholine o-sulfate-56[U-98% 2H]8
mMsNTD-57[U-80% 2H; 100% 15N-Tyr]0.05-0.109
10 mMsodium phosphate-589
100 mMsodium chloride-599
0.005 %Tween 20-609
0.5 mMTCEP-619
0.01 %sodium azide-629
0.5 MCholine o-sulfate-63[U-98% 2H]9
mMsNTD-64[U-80% 2H; 100% 1H, 100% 13C-Ala]0.05-0.1010
10 mMsodium phosphate-6510
100 mMsodium chloride-6610
0.005 %Tween 20-6710
0.5 mMTCEP-6810
0.01 %sodium azide-6910
0.5 MCholine o-sulfate-70[U-98% 2H]10
mMsNTD-71[U-80% 2H; 100% 1H, 100% 13C-Arg]0.05-0.1011
10 mMsodium phosphate-7211
100 mMsodium chloride-7311
0.005 %Tween 20-7411
0.5 mMTCEP-7511
0.01 %sodium azide-7611
0.5 MCholine o-sulfate-77[U-98% 2H]11
mMsNTD-78[U-80% 2H; 100% 1H, 100% 13C-Ile]0.05-0.1012
10 mMsodium phosphate-7912
100 mMsodium chloride-8012
0.005 %Tween 20-8112
0.5 mMTCEP-8212
0.01 %sodium azide-8312
0.5 MCholine o-sulfate-84[U-98% 2H]12
mMsNTD-85[U-80% 2H; 100% 1H, 100% 13C-Leu]0.05-0.1013
10 mMsodium phosphate-8613
100 mMsodium chloride-8713
0.005 %Tween 20-8813
0.5 mMTCEP-8913
0.01 %sodium azide-9013
0.5 MCholine o-sulfate-91[U-98% 2H]13
mMsNTD-92[U-80% 2H; 100% 1H, 100% 13C-Lys]0.05-0.1014
10 mMsodium phosphate-9314
100 mMsodium chloride-9414
0.005 %Tween 20-9514
0.5 mMTCEP-9614
0.01 %sodium azide-9714
0.5 MCholine o-sulfate-98[U-98% 2H]14
mMsNTD-99[U-80% 2H; 100% 1H, 100% 13C-Met]0.05-0.1015
10 mMsodium phosphate-10015
100 mMsodium chloride-10115
0.005 %Tween 20-10215
0.5 mMTCEP-10315
0.01 %sodium azide-10415
0.5 MCholine o-sulfate-105[U-98% 2H]15
mMsNTD-106[U-80% 2H; 100% 1H, 100% 13C-Phe]0.05-0.1016
10 mMsodium phosphate-10716
100 mMsodium chloride-10816
0.005 %Tween 20-10916
0.5 mMTCEP-11016
0.01 %sodium azide-11116
0.5 MCholine o-sulfate-112[U-98% 2H]16
mMsNTD-113[U-80% 2H; 100% 1H, 100% 13C-Thr]0.05-0.1017
10 mMsodium phosphate-11417
100 mMsodium chloride-11517
0.005 %Tween 20-11617
0.5 mMTCEP-11717
0.01 %sodium azide-11817
0.5 MCholine o-sulfate-119[U-98% 2H]17
mMsNTD-120[U-80% 2H; 100% 1H, 100% 13C-Tyr]0.05-0.1018
10 mMsodium phosphate-12118
100 mMsodium chloride-12218
0.005 %Tween 20-12318
0.5 mMTCEP-12418
0.01 %sodium azide-12518
0.5 MCholine o-sulfate-126[U-98% 2H]18
mMsNTD-127[U-80% 2H; 100% 1H, 100% 13C-Val]0.05-0.1019
10 mMsodium phosphate-12819
100 mMsodium chloride-12919
0.005 %Tween 20-13019
0.5 mMTCEP-13119
0.01 %sodium azide-13219
0.5 MCholine o-sulfate-133[U-98% 2H]19
mMsNTD-134[U-80% 2H; 100% 1H-Phe,Tyr,Ile]0.05-0.1020
10 mMsodium phosphate-13520
100 mMsodium chloride-13620
0.005 %Tween 20-13720
0.5 mMTCEP-13820
0.01 %sodium azide-13920
0.5 MCholine o-sulfate-140[U-98% 2H]20
mMsNTD-141[U-80% 2H; 100% 1H-Phe,Tyr,Leu]0.05-0.1021
10 mMsodium phosphate-14221
100 mMsodium chloride-14321
0.005 %Tween 20-14421
0.5 mMTCEP-14521
0.01 %sodium azide-14621
0.5 MCholine o-sulfate-147[U-98% 2H]21
mMsNTD-148[U-80% 2H; 100% 1H-Phe,Tyr,Val]0.05-0.1022
10 mMsodium phosphate-14922
100 mMsodium chloride-15022
0.005 %Tween 20-15122
0.5 mMTCEP-15222
0.01 %sodium azide-15322
0.5 MCholine o-sulfate-154[U-98% 2H]22
mMsNTD-155[U-80% 2H; 100% 1H-Trp,Ile,Leu,Val]0.05-0.1023
10 mMsodium phosphate-15623
100 mMsodium chloride-15723
0.005 %Tween 20-15823
0.5 mMTCEP-15923
0.01 %sodium azide-16023
0.5 MCholine o-sulfate-161[U-98% 2H]23
mMsNTD-1620.15-0.2024
10 mMsodium phosphate-16324
100 mMsodium chloride-16424
0.005 %Tween 20-16524
0.5 mMTCEP-16624
0.01 %sodium azide-16724
0.5 MCholine o-sulfate-168[U-98% 2H]24
Sample conditionspH: 7.3 / Pressure: ambient / Temperature: 298 K

-
NMR measurement

NMR spectrometer
TypeManufacturerModelField strength (MHz)Spectrometer-ID
Bruker AvanceBrukerAVANCE7001
Bruker AvanceBrukerAVANCE8502
Bruker AvanceBrukerAVANCE9003

-
Processing

NMR software
NameDeveloperClassification
TopSpinBruker Biospincollection
NMRPipeDelaglio, Grzesiek, Vuister, Zhu, Pfeifer and Baxprocessing
SparkyGoddarddata analysis
TALOSCornilescu, Delaglio and Baxestimation of dihedral angles
X-PLOR NIHSchwieters, Kuszewski, Tjandra and Clorestructure solution
MOLMOLKoradi, Billeter and Wuthrichdrawing structures
MacPyMolSchrodingerdrawing structures
ProcheckNMRLaskowski and MacArthurevaluation of structure quality
X-PLOR NIHSchwieters, Kuszewski, Tjandra and Clorerefinement
RefinementMethod: simulated annealing / Software ordinal: 1
NMR representativeSelection criteria: minimized average structure
NMR ensembleConformer selection criteria: structures with the lowest energy
Conformers calculated total number: 100 / Conformers submitted total number: 10

+
About Yorodumi

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbjlvh1.pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242)：Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi

Thousand views of thousand structures

  • Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
  • This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
  • The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.

Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi

Read more